Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hepatic veno-occlusive disease/phosphatase

Linkul este salvat în clipboard
ArticoleStudii cliniceBrevete
11 rezultate

Gemtuzumab ozogamicin (MylotargTM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND Gemtuzumab ozogamicin (GO) is approved for the treatment of older adults with acute myeloid leukemia in first relapse. Several reports have suggested an association between GO administration and hepatic veno-occlusive disease (VOD), which has recently been termed sinusoidal obstructive

Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Recent reports using historical controls or registry cohorts suggest, respectively, either an increase in the mortality or a decrease in the incidence of hepatic veno-occlusive disease (VOD) with the administration of intravenous immunoglobulin (i.v.Ig) after bone marrow transplantation. These

[Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient].

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
We report a 30 years old male, recipient of a kidney allograft and treated with azathioprine, who eighteen days after transplantation had a clinically asymptomatic elevation of total bilirubin and alkaline phosphatases. Nineteen months later, he presented with mild ascites, with a total bilirubin of

Bile duct adenocarcinoma mimicking veno-occlusive disease after autologous bone marrow transplantation for acute leukaemia.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
A 52-year-old female underwent autologous BMT because of acute myeloid leukaemia FAB M4 in second remission. Since the patient had no HLA-identical sibling she received a purged autologous BM transplant. On day +5 she developed signs of a sepsis syndrome with fluid retention and was treated with

Liver pathology following hepatic arterial infusion chemotherapy. Hepatic toxicity with FUDR.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
The authors reviewed the liver histopathology and the clinical features of eight patients with liver metastases from colorectal cancer who were treated by hepatic arterial infusion chemotherapy (HAIC) via an implantable pump (Infusaid). Before HAIC, these patients had no evidence of hepatitis, and

Hepatic arterial resistance index--an indicator of diffuse liver disease in children treated with bone marrow transplantation.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE To describe the relationship between the resistance index of the common hepatic artery and liver function tests in children undergoing bone marrow transplantation. METHODS We analysed prospectively the results of 106 Doppler ultrasound examinations of the common hepatic artery from 31 bone

Long non-coding RNAs expression profiles in hepatocytes of mice after hematopoietic stem cell transplantation.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Hepatic veno-occlusive disease (HVOD), one serious complication following hematopoietic stem cell transplantation (HSCT), is mainly initiated by the damage to sinusoidal endothelial cells and hepatocytes. Long non-coding RNAs (lncRNAs) play an important role in the proliferation of hepatocytes and

Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND Liver disease is an important cause of morbidity and mortality among recipients of bone-marrow transplantation (BMT). The aim of this retrospective study was to determine the incidence, risk factors and clinical evolution of liver disease following allogeneic BMT. METHODS A total of 103

Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Veno-occlusive disease continues to be a significant cause of morbidity and early mortality following bone marrow transplantation. This study retrospectively analyzes the incidence and risk factors for severe VOD in 350 patients treated with 4 days of busulfan (total 16 mg/kg) and 2 days of

A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND Human liver has an unusual sensitivity to radiation that limits its use in cancer therapy or in preconditioning for hepatocyte transplantation. Because the characteristic veno-occlusive lesions of radiation-induced liver disease do not occur in rodents, there has been no experimental

Histologic changes mimicking biliary disease in liver biopsies with venous outflow impairment.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Impairment of venous outflow from the liver manifests as zone 3 sinusoidal dilatation and congestion (SDC) in liver biopsy. The spectrum of histologic changes in portal tracts has not been described. We studied liver biopsies from 34 patients with a confirmed diagnosis of venous outflow impairment
Alăturați-vă paginii
noastre de facebook

Cea mai completă bază de date cu plante medicinale susținută de știință

  • Funcționează în 55 de limbi
  • Cure pe bază de plante susținute de știință
  • Recunoașterea ierburilor după imagine
  • Harta GPS interactivă - etichetați ierburile în locație (în curând)
  • Citiți publicațiile științifice legate de căutarea dvs.
  • Căutați plante medicinale după efectele lor
  • Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate

Google Play badgeApp Store badge